Harvard Heart Letter

Balancing bleeding vs. stroke risk when you have atrial fibrillation

Taking two kinds of blood thinners-anticoagulant and antiplatelet drugs-increases your risk of dangerous bleeding. But for some people with atrial fibrillation, the stroke-prevention benefit of this double therapy far outweighs the risk.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In